| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K26531177 |
| PharmacoGx | BRD-K26531177 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FAM9A | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-16 |
| mRNA | TEX13B | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-14 |
| mRNA | CCDC172 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-12 |
| mRNA | ADAMTS6 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | TIMD4 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | AC006386.1 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | RBMY1F | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | WNT2B | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | RP13-347D8.7 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | RBMY1J | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
